ArticleAnnals of the rheumatic diseases2018

Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.

Thomas Frisell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.